冠状病毒SARS-CoV-2核衣壳蛋白(S2NP)是该疾病的主要驱动因子，也是病毒复制和组装不可或缺的结构蛋白，但其在ROS生成中的作用尚未报道。2023年11月，华中科技大学同济医学院基础医学院刘超红教授团队在Journal of Medical Virology (IF 12.7) 上发表文章“SARS-CoV-2 nucleocapsid protein enhances the level of mi...
Coronavirus, SARS‐CoV‐2, can infect many species. Mink are very susceptible to SARS‐CoV‐2 infection, leading to virus mutations. Bio-Rad supplies antibodies to research on mink immunology.
Abstract Susceptibility to viral infection, development of immunity, response to treatment and patient clinical outcomes are all under the control of heritable factors in the host. In the context of the current SARS‐Cov‐2 pandemic, this review consi
majority of the SARS-CoV-2 infection was diagnosed in females, participants aged 41–50 years, and symptomatic participants. Participants aged ≤10 years and females recorded the highest viral load while participants aged 41–50 years recorded the highest number of infections. The SARS-CoV-...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the recent COVID-19 public health crisis. Bat is the widely believed original host of SARS-CoV-2. However, its intermediate host be...
The SARS-CoV-2 virus is tiny and invisible to the naked eye, and its presence in stools, droplets, and surfaces was detected. One doubt is whether insects can transmit the virus from one place to another. Thus, a healthy carrier of the COVID-19 virus can be at the root of the ...
Accurate rapid diagnostic tests for SARS‐CoV‐2 infection could contribute to clinical and public health strategies to manage the COVID‐19 pandemic. Point‐of‐care antigen and molecular tests to detect current infection could increase access to testing and early confirmation of cases, and expedia...
Acute skeletal muscle loss in SARS‐CoV‐2 infection contributes to poor clinical outcomes in COVID‐19 patients There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience....
Leslie C. Timpe PhD First published:24 January 2023 https://doi.org/10.1002/bmb.21711 Read thefull text PDF Tools Share No abstract is available for this article. REFERENCES Volume51,Issue2 March/April 2023 Pages209-211 This article also appears in: ...
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron variant is undergoing continuous evolution and convergent mutation. These new subvariants are raising concerns that they may evade neutralizing monoclonal antibodies (mAbs). We investigated the serum neutralization efficacy of Evus...